Aortic Stenosis Market Projected For Strong Expansion Through 2030: Key Trends And Future Outlook
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Aortic Stenosis Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The aortic stenosis market size has witnessed considerable growth in recent years. It is anticipated to increase from $8.91 billion in 2025 to $10.06 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.9%. This historical growth can be ascribed to an aging global population, the increasing prevalence of degenerative heart valve diseases, the expansion of cardiac catheterization labs, enhancements in surgical valve replacement techniques, and a rising clinical awareness of valvular disorders.
The aortic stenosis market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $16.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. The projected growth can be linked to several factors, including heightened investments in advanced valve technologies, the increasing acceptance of TAVR procedures, the spread of outpatient cardiac care models, an enhanced emphasis on early intervention approaches, and the greater incorporation of digital cardiac monitoring instruments. Key developments expected during this period involve a wider embrace of transcatheter valve replacement procedures, a growing preference for minimally invasive cardiac treatments, the expanded application of sophisticated diagnostic imaging, the development of customized valve therapy options, and a stronger concentration on identifying diseases early.
Get A Free Sample Report With In-Depth Market Insights:
Aortic Stenosis Market Growth Catalysts And Demand Drivers
The future expansion of the aortic stenosis market is anticipated to be driven by the rising incidence of heart conditions. Heart diseases encompass various ailments that impact the heart’s structure and its operational capabilities. Such conditions can impair the heart’s efficiency in circulating blood, resulting in subsequent complications. Common cardiac ailments include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, and cardiomyopathy, among others. Aortic stenosis is characterized by a constriction of the aortic valve, hindering the passage of blood from the left ventricle into the aorta. This heightened resistance compels the heart to exert greater effort, potentially culminating in heart failure and additional cardiovascular issues over time. Effective management of aortic stenosis, through interventions like valve replacement or TAVI, aids in enhancing cardiac performance and diminishing the likelihood of serious heart disease consequences. As an illustration, data from January 2025 by the British Heart Foundation, a UK cardiovascular research charity, indicated that approximately 7.6 million individuals in the UK are affected by heart and circulatory conditions, comprising around 4 million males and 3.6 million females. These ailments contribute to approximately 27% of all fatalities in the UK, causing over 170,000 deaths each year, which translates to 480 deaths daily. Consequently, the expanding incidence of heart diseases is fueling the development of the aortic stenosis market.
Aortic Stenosis Market Segmentation: How Does The Market Break Down By Category?
The aortic stenosis market covered in this report is segmented –
1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis
2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty
3) By End User: Hospitals and Cardiac Centers, Ambulatory Surgical Centers, Cardiac Surgeons and Interventional Cardiologists
Subsegments:
1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis
2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis
Aortic Stenosis Market Trends Shaping Long-Term Demand
Leading companies in the aortic stenosis market are prioritizing the development of innovative aortic valve technologies, such as transcatheter aortic valve implantation (TAVI) systems, to enhance patient outcomes, minimize procedural risks, and improve the overall effectiveness of aortic treatment. The transcatheter aortic valve implantation (TAVI) system itself is a minimally invasive medical device that facilitates the replacement of a diseased aortic valve without requiring open-heart surgery. For instance, in January 2023, Abbott Laboratories, a US-based medical device company, obtained approval from the U.S. Food and Drug Administration (FDA) for Navitor, a cutting-edge transcatheter aortic valve implantation (TAVI) system. Navitor features the NaviSeal fabric cuff, designed to reduce or eliminate paravalvular leaks. Moreover, the system’s design, which places leaflets within the native valve, aims to improve access to coronary arteries for future treatments of coronary artery disease.
Aortic Stenosis Market Competitive Overview And Top Companies
Major companies operating in the aortic stenosis market are Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, Boston Scientific Corporation, Terumo Corporation, LivaNova PLC, CryoLife Inc, Anteris Technologies Ltd, Venus Medtech, Peijia Medical, MicroPort Scientific Corporation, Lepu Medical Technology Co Ltd, Symetis SA, Artivion Inc, HighLife SAS, Transcatheter Technologies GmbH, NaviGate Cardiac Structures Inc, Xeltis BV, Sorin Group, Meril Life Sciences Pvt Ltd, On-X Life Technologies Inc, Braile Biomédica, Colibri Heart Valve
View The Full Aortic Stenosis Market Report:
Aortic Stenosis Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the aortic stenosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
